GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jushi Holdings Inc (OTCPK:JUSHF) » Definitions » EV-to-EBIT

Jushi Holdings (Jushi Holdings) EV-to-EBIT : 107.04 (As of Apr. 30, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Jushi Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Jushi Holdings's Enterprise Value is $402.6 Mil. Jushi Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $3.8 Mil. Therefore, Jushi Holdings's EV-to-EBIT for today is 107.04.

The historical rank and industry rank for Jushi Holdings's EV-to-EBIT or its related term are showing as below:

JUSHF' s EV-to-EBIT Range Over the Past 10 Years
Min: -24.7   Med: -3.09   Max: 174.93
Current: 107.04

During the past 13 years, the highest EV-to-EBIT of Jushi Holdings was 174.93. The lowest was -24.70. And the median was -3.09.

JUSHF's EV-to-EBIT is ranked worse than
94.76% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.14 vs JUSHF: 107.04

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Jushi Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was $361.9 Mil. Jushi Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $3.8 Mil. Jushi Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.04%.


Jushi Holdings EV-to-EBIT Historical Data

The historical data trend for Jushi Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jushi Holdings EV-to-EBIT Chart

Jushi Holdings Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.54 -4.78 9.18 -3.07 95.93

Jushi Holdings Quarterly Data
Feb19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.07 -2.84 -2.07 -3.36 95.93

Competitive Comparison of Jushi Holdings's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jushi Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jushi Holdings's EV-to-EBIT falls into.



Jushi Holdings EV-to-EBIT Calculation

Jushi Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=402.585/3.761
=107.04

Jushi Holdings's current Enterprise Value is $402.6 Mil.
Jushi Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jushi Holdings  (OTCPK:JUSHF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Jushi Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=3.761/361.87758528
=1.04 %

Jushi Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was $361.9 Mil.
Jushi Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jushi Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Jushi Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Jushi Holdings (Jushi Holdings) Business Description

Traded in Other Exchanges
Address
301 Yamato Road, Suite 3250, Boca Raton, FL, USA, 33431
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator across the United States. The company operates a diverse portfolio of branded cannabis and hemp-derived assets, built upon opportunistic acquisitions, distressed deals and competitive applications. Operating under the Jushi umbrella is the BEYOND / HELLO retail brand of cannabis dispensaries, hemp-based CBD brand, Nira, including its brands, The Lab: Concentrates and The Bank: Flower + Genetics, as well as its precision formulated line of medical cannabis products Nira Plus. Jushi strives to maximize shareholder value while delivering high premium products across all levels of the cannabis and hemp ecosystem.